Stockreport

Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline

Foghorn Therapeutics Inc.  (FHTX) 
PDF Positions company to further leverage strength of platform and advance programs through multiple data readouts and clinical value inflection points Strengthens ba [Read more]